市场调查报告书
商品编码
1423211
2024-2032 年按产品类型、材料、手术类型、适应症和地区分類的心血管植入物市场报告Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2024-2032 |
2023年,全球心血管植入物市场规模达到2,61亿美元。展望未来, IMARC Group预计到2032年市场规模将达到433亿美元,2024-2032年复合年增长率(CAGR)为5.6%。心血管疾病盛行率上升、老年人口不断扩大以及医疗保健产业的显着进步是推动市场发展的一些关键因素。
心血管植入物是用于治疗各种心血管疾病(CVD)的专用医疗工具,包括心臟衰竭、冠状动脉疾病、週边动脉疾病、主动脉疾病和心肌梗塞。它们安装在体内,以支持心臟和血管的正常功能,并减轻与心律异常相关的症状。这些设备由钛、热解碳、硅胶和塑胶网製成,并配备植入式心律转復除颤器 (ICD) 产生器和聚氨酯 (PU) 聚合物绝缘的电线。心血管植入物可以检测严重的心律并发送讯号以维持正常的心臟功能。
The global cardiovascular implants market size reached US$ 26.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 43.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The rising prevalence of cardiovascular diseases, the expanding geriatric population, and significant advancements in the healthcare sector represent some of the key factors driving the market.
Cardiovascular implants are specialized medical tools used to treat various cardiovascular diseases (CVDs), including heart failure, coronary artery disease, peripheral arterial disease, aortic disease, and myocardial infarction. They are fitted inside the body to support the proper functioning of the heart and blood vessels and to alleviate symptoms associated with abnormal heart rhythms. These devices are made from titanium, pyrolytic carbon, silicone, and plastic mesh and are equipped with an implantable cardioverter-defibrillator (ICD) generator and wires that are insulated with polyurethane (PU) polymer. Cardiovascular implants can detect severe heart rhythms and send signals to maintain normal heart function.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiovascular implants market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, material, procedure type and indication.
Coronary Stent
ICD
Heart Valve
Implanted Cardiac Pacemaker
CRT Device
Peripheral Stent
The report has provided a detailed breakup and analysis of the cardiovascular implants market based on the product type. This includes coronary stent, ICD, heart valve, implanted cardiac pacemaker, CRT device, and peripheral stent. According to the report, ICD represented the largest segment.
Metals and Alloys
Polymers
Biological Materials
A detailed breakup and analysis of the cardiovascular implants market based on the material has also been provided in the report. This includes metals and alloys, polymers, and biological materials.
Angioplasty
Open Heart Surgery
The report has provided a detailed breakup and analysis of the cardiovascular implants market based on the procedure type. This includes angioplasty and open heart surgery.
Arrhythmias
Myocardial Ischemia
Acute Myocardial Infarction
Congestive Heart Failure
Others
A detailed breakup and analysis of the cardiovascular implants market based on the indication type has also been provided in the report. This includes arrhythmias, myocardial ischemia, acute myocardial infarction, congestive heart failure, and others. According to the report, arrhythmias accounted for the largest market share.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for cardiovascular implants. Some of the factors driving the North America cardiovascular implants market included the rising prevalence of CVDs, innovative product advancements, and the growing geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global cardiovascular implants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include BIOTRONIK SE & Co. KG, Abbott Laboratories, AMG International, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation, Edwards Lifesciences Corporation, Fortimedix Surgical B.V., Neovasc Inc., CryoLife Inc., Proxy Biomedical Ltd., REVA Medical, LLC., and Shree Pacetronix Ltd.